Effective diabetes management requires a shift from focusing purely on blood sugar levels and weight management medications to embracing the psychological and biological contributors that drive obesity and the disease.
Abbott recently launched the FreeStyle Libre 3 Plus sensor, which it says is the smallest and most discreet sensor on the market. It will soon be available in U.S. retail pharmacies and medical equipment suppliers.
Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.
Biolinq raked in $58 million in capital this week. The company is developing a wearable patch that uses electrochemical sensors to measure a person’s glucose levels from the intradermal space just beneath the surface of their skin.
Simply put, there’s no turning back from the digital transformation that’s underway and continuing to pick up steam. This is why it’s critical for the people who design and use healthcare technology to always consider the influence it can have.
Livongo and Dexcom struck a partnership on Monday that would combine Dexcom’s continuous glucose monitors with Livongo’s software. At the StartUp Health Conference, Livongo President Jennifer Schneider said its work with Dexcom would create a new stream of data for both companies.
An alternative way of testing glucose levels without finger pricking is a great solution for young kids and teens.
When it comes to managing inbound phone calls, underperformance has devastating cost implications.
More than 29 million Americans have diabetes and 86 million have prediabetes. Purdue University researchers are focusing on new innovations in treatment.
A research team at the University of Virginia School of Medicine is looking to automate the monitoring of blood glucose levels and insulin for type 1 diabetes patients.